SVB Leerink Downgrades Moderna (MRNA) to Underperform
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $172.94 --0%
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 33
Rating Summary:
7 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 33
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar downgraded Moderna (NASDAQ: MRNA) from Market Perform to Underperform with a price target of $93.00 (from $111.00).
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $147.57 yesterday.
You May Also Be Interested In
- Tyra Biosciences (TYRA) PT Lowered to $29 at H.C. Wainwright
- Twilio (TWLO) PT Raised to $290 at Rosenblatt
- Moderna shares climb on cancer vaccine momentum
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
